TAMPA, FLORIDA / ACCESS Newswire / October 14, 2025 / Bionic Bloom, an innovator in integrative psychiatry and psychedelic-assisted therapy, has entered into an agreement with NBX Wellness to deliver nutrigenomic testing and customized wellness solutions.
The partnership integrates NBX's proprietary genetic testing platform into Bionic Bloom's clinical operations, enabling practitioners to map individual genetic markers and create data-driven plans for detoxification, supplementation, and peptide therapy.
"This partnership with NBX Wellness positions Bionic Bloom at the forefront of personalized medicine," said Dr. Angela Fisher, PhD, Founder and Medical Director. "It's a strategic alignment that enhances our service offerings and underscores our commitment to evidence-based, individualized care."
The agreement also reflects the growing demand for genetic insights in wellness and mental health care, a field projected to expand significantly in the coming decade.
Contact:
Ethan Owens 727-490-9911
SOURCE: Bionic Bloom
View the original press release on ACCESS Newswire